These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32506168)

  • 21. Cancer stem cells in glioblastoma.
    Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
    Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional control of brain tumor stem cells by a carbohydrate binding protein.
    Sharanek A; Burban A; Hernandez-Corchado A; Madrigal A; Fatakdawala I; Najafabadi HS; Soleimani VD; Jahani-Asl A
    Cell Rep; 2021 Aug; 36(9):109647. PubMed ID: 34469737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioblastoma Stem Cells: Driving Resilience through Chaos.
    Prager BC; Bhargava S; Mahadev V; Hubert CG; Rich JN
    Trends Cancer; 2020 Mar; 6(3):223-235. PubMed ID: 32101725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model.
    Saga I; Shibao S; Okubo J; Osuka S; Kobayashi Y; Yamada S; Fujita S; Urakami K; Kusuhara M; Yoshida K; Saya H; Sampetrean O
    Neuro Oncol; 2014 Aug; 16(8):1048-56. PubMed ID: 24860177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MALT1 in glioblastoma: the Flowers of Evil].
    Maghe C; Jacobs KA; Bidère N; Gavard J
    Med Sci (Paris); 2020 May; 36(5):452-454. PubMed ID: 32452364
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?
    Sloan AR; Silver DJ; Kint S; Gallo M; Lathia JD
    Neuro Oncol; 2024 May; 26(5):785-795. PubMed ID: 38394444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting brain-tumor stem cells.
    Stupp R; Hegi ME
    Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
    [No Abstract]   [Full Text] [Related]  

  • 29. Extrachromosomal DNA: Redefining the pathogenesis of glioblastoma.
    Shiras A; Mondal A
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188551. PubMed ID: 33892052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glioma stem cell maintenance: the role of the microenvironment.
    Heddleston JM; Hitomi M; Venere M; Flavahan WA; Yang K; Kim Y; Minhas S; Rich JN; Hjelmeland AB
    Curr Pharm Des; 2011; 17(23):2386-401. PubMed ID: 21827414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
    Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
    Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression.
    Ferrarese R; Harsh GR; Yadav AK; Bug E; Maticzka D; Reichardt W; Dombrowski SM; Miller TE; Masilamani AP; Dai F; Kim H; Hadler M; Scholtens DM; Yu IL; Beck J; Srinivasasainagendra V; Costa F; Baxan N; Pfeifer D; von Elverfeldt D; Backofen R; Weyerbrock A; Duarte CW; He X; Prinz M; Chandler JP; Vogel H; Chakravarti A; Rich JN; Carro MS; Bredel M
    J Clin Invest; 2014 Jul; 124(7):2861-76. PubMed ID: 24865424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas.
    Muñoz DM; Guha A
    Oncotarget; 2011 Aug; 2(8):590-8. PubMed ID: 21896959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The angiogenic switch leads to a metabolic shift in human glioblastoma.
    Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
    Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
    Gao X; Jin W
    Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma.
    Wang G; Fu XL; Wang JJ; Guan R; Tang XJ
    Curr Cancer Drug Targets; 2017; 17(1):17-39. PubMed ID: 27562399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.
    Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C
    PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.
    Suvà ML; Rheinbay E; Gillespie SM; Patel AP; Wakimoto H; Rabkin SD; Riggi N; Chi AS; Cahill DP; Nahed BV; Curry WT; Martuza RL; Rivera MN; Rossetti N; Kasif S; Beik S; Kadri S; Tirosh I; Wortman I; Shalek AK; Rozenblatt-Rosen O; Regev A; Louis DN; Bernstein BE
    Cell; 2014 Apr; 157(3):580-94. PubMed ID: 24726434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.